FREE SHIPPING on orders over $59 | 100% Happiness Guarantee | 📞 877-564-5756 | ✉️ info@bioabsorbnutraceuticals.com

Does vitamin C help repair arteries?

Does vitamin C help repair arteries?

Vitamin C builds the collagen that holds an artery wall together, which is why severe deficiency makes blood vessels leak and bleed.

So does vitamin C help repair arteries? Not in the way most people mean it. It will not clear plaque. In a trial that randomised 14,641 men to 500 mg a day or placebo over a median of 8 years, major cardiovascular events did not fall at all.

Here is what it genuinely does, where the repair idea came from, and what happened when trials measured real arteries.

Key Takeaways

Table of Contents

1. Does Vitamin C Help Repair Arteries? The Short Answer

The honest answer has three parts, and they are often blurred together.

  • Building and maintaining the artery wall: established. Your arteries are held together by collagen, and vitamin C is required to make it. This is not disputed by anyone.
  • Improving how the vessel lining behaves: real, but narrow. Vitamin C improves blood vessel function in people who already have diabetes, heart failure or artery disease. In healthy people, it does nothing measurable.
  • Repairing or clearing existing plaque: not shown. No trial has found that vitamin C supplements reverse atherosclerosis or reduce heart attacks and strokes.

The gap between the first point and the third is where most of the confusion lives. "Your body cannot build arteries without it" is true. "Taking more of it rebuilds damaged ones" does not follow, and when researchers tested that step directly, it did not hold up.

If you have been told you have narrowed or hardened arteries, this is not a supplement question. It is a conversation with your doctor about blood pressure, cholesterol, smoking and the treatments that do have outcome evidence behind them.

2. What Vitamin C Actually Does in an Artery Wall

Collagen is the structural protein that gives arteries their strength and flex. Making it involves a chemical step called hydroxylation, and vitamin C is the cofactor that step cannot run without. Without enough of it, collagen never forms its stable triple-helix shape, and the tissue built from it is weak.

You can see what that looks like in scurvy. Gums bleed, bruises appear easily, and tiny haemorrhages show up under the skin and nails. Those are not separate symptoms. They are all the same thing: blood vessel walls built from faulty collagen, giving way.

So vitamin C is genuinely load-bearing for your arteries. The catch is how little of it the job takes. The amount needed to keep collagen synthesis running normally sits close to the recommended daily intake, which the NIH puts at 90 mg a day for men and 75 mg for women. Once that requirement is met, adding more does not make collagen any more correct. The enzyme is not waiting for extra.

That is why "vitamin C is essential for artery walls" and "more vitamin C repairs artery walls" are not the same sentence. Our guide to how much vitamin C to take per day covers where the benchmarks sit.

3. Where the Repair Idea Came From: Pauling, Rath and Lp(a)

Almost every "vitamin C repairs arteries" article online traces back to two papers published in 1990.

Linus Pauling and Matthias Rath proposed that lipoprotein(a) acts as a stand-in for vitamin C. Their argument ran like this: humans lost the ability to make their own vitamin C, so when collagen maintenance falters, the body patches weakened vessel walls with a sticky particle called Lp(a) instead. Atherosclerosis, on this account, is low-grade chronic scurvy, and the fix is large doses of vitamin C plus the amino acid lysine. They backed it with guinea pigs deprived of vitamin C, which developed arterial lesions with Lp(a) in them.

Here is the fair scorecard, more than three decades on.

They were early on the right molecule. Lp(a) was treated as a curiosity in 1990. It is now taken seriously as an independent cardiovascular risk factor, with drugs in development that target it specifically. That deserves credit.

The vitamin C part did not transfer. Guinea pigs on a vitamin C-free diet develop actual scurvy. People eating an ordinary, even mediocre, diet do not. Later human work did not find that vitamin C meaningfully lowers Lp(a), and the scurvy lesion and the atherosclerotic plaque are not the same thing under a microscope.

The combination was never properly tested. There is still no randomised controlled trial of vitamin C plus lysine on cardiovascular outcomes. Not a positive one, not a negative one. Being right that Lp(a) matters is not the same as being right about what fixes it. Our article on high-dose vitamin C, megadosing and Pauling covers that history in more detail.

4. What Vitamin C Does to Blood Vessel Function

This is where vitamin C has its strongest cardiovascular evidence, and also where it is most often oversold.

The inner lining of a blood vessel, the endothelium, controls how the vessel widens and narrows. Researchers test it by measuring how much an artery dilates when blood flow increases. Pooling 44 randomised trials covering 1,129 adults, vitamin C produced a clear improvement in that response.

Two details matter more than the headline.

First, who it worked for. The benefit was concentrated in people with existing problems: atherosclerosis, diabetes, heart failure. In healthy volunteers there was no effect. Vitamin C was correcting something, not adding something.

Second, what was measured. Dilation is a measure of how a vessel behaves on the day of the test. It is not a measure of whether plaque shrank. The two can move independently, and a surrogate marker improving is the beginning of an argument, not the end of one.

Arterial stiffness tells a similar story. A meta-analysis of antioxidant vitamins found a small reduction in pulse wave velocity of 0.20 metres per second, with the biggest effect in people who started with low vitamin C levels. Notably, vitamin C at 4 grams a day did not reduce stiffness at all. Higher doses did not buy a bigger effect.

And when vitamin C and vitamin E were given together, the combination stopped working, even though each alone had helped. Antioxidants are not additive, and stacking them is not a strategy.

5. What Happened When Trials Measured Real Arteries

Surrogate markers are cheap and fast. Outcomes are slow and expensive, and they are the ones that count. Four pieces of evidence point the same way.

Healthy men, 8 years. The Physicians' Health Study II randomised 14,641 men to 500 mg of vitamin C a day or to placebo, for a median of 8 years. There were 1,245 confirmed major cardiovascular events and no reduction against placebo.

High-risk women, 9.4 years. The Women's Antioxidant Cardiovascular Study enrolled 8,171 women who already had vascular disease or three or more risk factors. On 500 mg a day over a mean 9.4 years, 1,450 of them had at least one cardiovascular event. There was no overall effect on the combined endpoint or on heart attack, stroke, revascularisation or cardiovascular death individually. These were exactly the people an artery-repair claim is aimed at.

The systematic review. Cochrane assessed the evidence and reported a hazard ratio of 0.99, with a confidence interval from 0.89 to 1.10. Their conclusion was that there is currently no evidence that vitamin C supplementation reduces cardiovascular risk. They also graded that evidence as low quality, because it rests heavily on one trial population.

The genetic test. Observational studies have long shown that people with higher blood vitamin C have less heart disease, but those people also tend to eat better, smoke less and exercise more. A Mendelian randomisation study got around that by using genetic variants that raise vitamin C levels for life, across 15 cardiovascular endpoints and up to 139,364 coronary artery disease cases. A lifetime of genetically higher vitamin C did not translate into less coronary artery disease.

There is one result that points the other way, and it belongs here. In the ASAP trial, 520 adults with high cholesterol took vitamin C and vitamin E together for six years, and the thickening of the carotid artery wall slowed by 26%. The effect reached significance in men and not in women. It is a genuine finding, but it tested a combination rather than vitamin C alone, and slowing how fast a wall thickens is not the same as repairing one.

6. The Uncomfortable Finding: Food and Supplements Went Opposite Ways

This one is worth stating plainly, because it is awkward for anyone selling vitamin C.

The Los Angeles Atherosclerosis Study followed 573 adults aged 40 to 60 and measured their carotid artery wall thickness by ultrasound three times over three years. Among people taking vitamin C supplements, wall thickening got faster as the dose went up. In the highest group, 857 to 5,000 mg a day, arteries thickened roughly three times faster than in people taking no vitamin C supplement at all. Vitamin C from food showed the opposite pattern.

Several things are true about this at once, and all of them should be said.

  • It is observational. Nobody was randomly assigned to a dose, so the people taking 3 grams a day may have differed from everyone else in ways the study could not fully account for, including being worried about their hearts in the first place.
  • It is one cohort. It has not been replicated, and a single prospective study does not overturn a field.
  • It is also the only study here that pointed an ultrasound at artery walls and compared them against supplement dose. On the specific question this article asks, it is uncomfortably on topic, and it did not find repair.

The broader pattern it fits is familiar in nutrition research: the nutrient in food keeps looking protective while the isolated nutrient in a capsule does not reproduce the effect. That is one reason our article on foods high in vitamin C treats diet as the baseline rather than an afterthought.

7. Does Better Absorption Change the Answer?

It is a reasonable question, and it is the one this site exists to take seriously. Plain vitamin C is absorbed less efficiently above 500 mg at a time, and liposomal encapsulation is built to work around that. A 2025 scoping review of ten trials found that nine reported higher bioavailability for liposomal vitamin C, with total blood exposure roughly 1.3 to 7.2 times that of plain vitamin C. Our complete guide to liposomal vitamin C sets out how the delivery system works.

So does more of it in the blood mean more protection for a vessel? One study has actually tested something close to that.

Eleven adults were given 4 grams of vitamin C on four separate occasions: as a placebo, plain oral, liposomal oral, and intravenously. The researchers then clamped a cuff on the forearm to cut off blood flow and release it, which produces a burst of oxidative stress in the vessel. Liposomal vitamin C did raise blood levels above plain oral, as expected. But when it came to blunting that oxidative stress, all three forms performed about the same. Liposomal was no better than the plain tablet.

That is one small study of a single endpoint, and it should not be stretched either. But it illustrates the honest position on this whole topic: the absorption advantage of liposomal delivery is established, and a clinical outcome advantage is not. Getting more of a nutrient into circulation is only useful if more of it in circulation does something, and for arteries that second step has not been demonstrated. Our guides to vitamin C absorption and whether liposomal vitamin C is better hold the same line.

What Bio Absorb Liposomal Vitamin C Is For, and What It Isn't

Bio Absorb Nutraceuticals makes liposomal vitamin C in two formats. The Liposomal Vitamin C Liquid 1000mg (Corn-Free) has a natural orange flavour and mixes into water or juice, so you can measure what you want. The Liposomal Vitamin C Capsules 1000mg (Corn-Free) have no taste, need no refrigeration and travel well.

Both use liposomal delivery, with the vitamin C encapsulated in phospholipids. Both are verified corn-free, non-GMO, gluten-free, nut-free, dairy-free and vegan. Both are made in a GMP-certified facility in Canada, every batch is third-party tested, and both carry a 100% money-back guarantee.

What we are not going to tell you is that either one repairs arteries. The evidence in this article is ours to read as much as anyone's, and it does not support that claim. A liposomal format is a sensible choice if you want vitamin C for the things vitamin C is actually established for, and you would rather absorb more of what you take. It is not a cardiovascular treatment, and we would rather say so here than let you find out later.

If that is the use you have in mind, see the current pricing and serving details for the liquid or the full product specification for the capsules, and keep your total from all sources under the 2,000 mg daily upper limit. If you are being treated for heart or circulatory problems, bring the product page to your doctor rather than making the decision from a blog post.

Frequently Asked Questions

Can vitamin C reverse or unclog artery plaque?

No trial has shown that. The largest randomised trials of vitamin C found no reduction in major cardiovascular events over 8 years, and Cochrane's review reached the same conclusion. Treatments that are proven to slow or stabilise plaque exist, and they come from your doctor.

Does vitamin C strengthen blood vessel walls?

It is required to build them. Vitamin C is the cofactor for collagen synthesis, and a deficiency produces fragile vessels that bleed. What has not been shown is that going above your requirement strengthens walls further. Correcting a shortfall and adding a surplus are different things.

Is the Pauling protocol of vitamin C and lysine proven?

No. It began as a 1990 hypothesis paper supported by guinea pig work, and more than thirty years later there is still no randomised controlled trial of the combination on cardiovascular outcomes. The Lp(a) particle at the centre of the idea did turn out to matter, but that is a separate point from whether vitamin C and lysine address it.

How much vitamin C is good for your heart?

There is no cardiac dose, because no dose has been shown to change cardiac outcomes. The RDA is 90 mg a day for men and 75 mg for women, with 35 mg more for people who smoke, and the adult upper limit is 2,000 mg a day from food and supplements combined. Taking more is not a cardiovascular strategy; in one stiffness analysis, 4 grams a day did nothing that lower doses had not already done.

Does liposomal vitamin C work better for arteries?

It gets more vitamin C into your blood, which is well documented. Whether that produces a vascular benefit is a separate question, and in the one study to test a vessel endpoint directly, liposomal was no more protective than plain oral vitamin C. The absorption advantage is established. An artery advantage is not. Our guide to whether liposomal vitamin C is better goes further into where the format does and does not earn its place.

Should I take vitamin C if I have heart disease or take a statin?

Ask your prescriber first. Antioxidant supplements including vitamin C have been reported to interact with statin and niacin therapy, and anyone with kidney stones, kidney disease or an iron-overload condition such as haemochromatosis should take medical advice before supplementing. Our article on vitamin C interactions with medications and supplements covers the documented ones. Starting a supplement is the moment to mention it, not something to decide alone.

Conclusion

Does vitamin C help repair arteries? It builds the collagen your arteries are made from, and in people who are already unwell it improves how blood vessels respond. It does not clear plaque, and across tens of thousands of people in randomised trials it did not reduce heart attacks, strokes or cardiovascular deaths. That is a nutrient doing its job, not a treatment doing yours. If you want vitamin C for what it is genuinely established to do, see current pricing and serving details for Bio Absorb Liposomal Vitamin C, and keep the artery conversation with your doctor.

Research References

  1. Effect of vitamin C on endothelial function in health and disease: A systematic review and meta-analysis of randomised controlled trials. Atherosclerosis, Vol. 235, Issue 1 (2014), pp. 9-20. Pooled 44 trials and 1,129 participants; benefit concentrated in atherosclerosis, diabetes and heart failure, with no effect in healthy volunteers.
  2. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA, Vol. 300, Issue 18 (2008), pp. 2123-2133. 14,641 men randomised to 500 mg a day or placebo for a median 8 years; 1,245 major cardiovascular events and no reduction versus placebo.
  3. A Randomized Factorial Trial of Vitamins C and E and Beta Carotene in the Secondary Prevention of Cardiovascular Events in Women. Archives of Internal Medicine, Vol. 167, Issue 15 (2007), pp. 1610-1618. 8,171 high-risk women on 500 mg a day for a mean 9.4 years; no overall effect on cardiovascular events.
  4. Vitamin C supplementation for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews, 2017, Issue 3, Art. No. CD011114. doi:10.1002/14651858.CD011114.pub2. Major cardiovascular events hazard ratio 0.99, 95% CI 0.89 to 1.10; evidence graded low quality.
  5. Differing Relations to Early Atherosclerosis between Vitamin C from Supplements vs. Food in the Los Angeles Atherosclerosis Study. The Open Cardiovascular Medicine Journal, Vol. 6 (2012), pp. 113-121. In 573 adults over 3 years, carotid wall thickening rose with supplement dose (P-trend 0.0009) while dietary vitamin C was protective.
  6. Antioxidant Vitamin Supplementation Reduces Arterial Stiffness in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. The Journal of Nutrition (2014) [volume and issue not confirmed]. Pulse wave velocity fell 0.20 m/s across 8 studies and 1,453 participants; vitamin C at 4 g a day produced no reduction.
  7. Effect of vitamin C and vitamin E supplementation on endothelial function: a systematic review and meta-analysis of randomised controlled trials. British Journal of Nutrition, Vol. 113, Issue 8 (2015). Vitamin C alone improved endothelial function; the two vitamins co-administered did not.
  8. Liposomal-encapsulated Ascorbic Acid: Influence on Vitamin C Bioavailability and Capacity to Protect Against Ischemia-Reperfusion Injury. Nutrition and Metabolic Insights, Vol. 9 (2016), pp. 25-30. In 11 adults given 4 g, liposomal raised blood levels above plain oral but protected against oxidative stress no better than plain oral or intravenous.
  9. Genetically predicted circulating vitamin C in relation to cardiovascular disease. European Journal of Preventive Cardiology (2022) [volume and issue not confirmed]. Mendelian randomisation across 15 cardiovascular endpoints and up to 139,364 coronary artery disease cases found no protective effect on coronary artery disease.
  10. Hypothesis: lipoprotein(a) is a surrogate for ascorbate. Proceedings of the National Academy of Sciences of the USA, Vol. 87, Issue 16 (1990), pp. 6204-6207. The original Rath and Pauling proposal that Lp(a) patches vessel walls when ascorbate is scarce.
  11. Immunological evidence for the accumulation of lipoprotein(a) in the atherosclerotic lesion of the hypoascorbemic guinea pig. Proceedings of the National Academy of Sciences of the USA, Vol. 87, Issue 23 (1990), pp. 9388-9390. The guinea pig evidence behind the hypothesis.
  12. Vitamin C and Cardiovascular Disease: An Update. Antioxidants, Vol. 9, Issue 12 (2020), article 1227. Review of the clinical and preclinical evidence; source for the ASAP trial result of 26% slower carotid wall thickening on combined vitamin C and E.
  13. Vitamin C (Ascorbic Acid). StatPearls, NCBI Bookshelf, National Library of Medicine. Vitamin C as the required cofactor for proline and lysine hydroxylation in collagen synthesis, and the vessel wall fragility that follows deficiency.
  14. Vitamin C: Fact Sheet for Health Professionals. National Institutes of Health, Office of Dietary Supplements. Source for the RDA, the additional requirement for smokers, and the 2,000 mg adult upper limit covering food and supplements together.
  15. Vitamin C. Linus Pauling Institute Micronutrient Information Center, Oregon State University. Absorption efficiency falls above 500 mg taken at one time.
  16. Do Liposomal Vitamin C Formulations Have Improved Bioavailability? Scoping review (2025) [journal, volume and URL NEEDED]. Reviewed 10 published trials; 9 reported higher bioavailability for liposomal vitamin C, with AUC 1.3–7.2 times higher than non-liposomal forms, and no clinical outcome data. The same source is already cited on the live Iron Absorption and Corn-Free articles — copy the full citation and URL from one of those before publishing.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.


Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.